a Retrospective, Multinational, Multicenter Study on the Natural History of Infantile-Onset Pompe Disease
Product Description:
The enzymatic defect in Pompe disease is insufficient lysosomal acid α-glucosidase (GAA) activity which leads to lysosomal glycogen accumulation. We recently introduced a simple and reliable method to measure GAA activity in dried blood spots using Acarbose, a highly selective α-glucosidase inhibitor, to eliminate isoenzyme interference. Here we demonstrate that this method efficiently detects late-onset Pompe patients who are frequently misdiagnosed by conventional methods due to residual GAA activity in other tissue types.
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Consumers/Families, Professionals, Students
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A